Inhibition of human α-methylacyl CoA racemase (AMACR): a target for prostate cancer.
about
Lipid metabolism in prostate cancerInhibitor of differentiation 4 (ID4) inactivation promotes de novo steroidogenesis and castration-resistant prostate cancer.Silibinin inhibits aberrant lipid metabolism, proliferation and emergence of androgen-independence in prostate cancer cells via primarily targeting the sterol response element binding protein 1.A study on the AMACR catalysed elimination reaction and its application to inhibitor testing.
P2860
Inhibition of human α-methylacyl CoA racemase (AMACR): a target for prostate cancer.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Inhibition of human α-methylacyl CoA racemase (AMACR): a target for prostate cancer.
@en
Inhibition of human α-methylacyl CoA racemase
@nl
type
label
Inhibition of human α-methylacyl CoA racemase (AMACR): a target for prostate cancer.
@en
Inhibition of human α-methylacyl CoA racemase
@nl
prefLabel
Inhibition of human α-methylacyl CoA racemase (AMACR): a target for prostate cancer.
@en
Inhibition of human α-methylacyl CoA racemase
@nl
P2093
P2860
P356
P1433
P1476
Inhibition of human α-methylacyl CoA racemase (AMACR): a target for prostate cancer.
@en
P2093
Lu-Yun Lian
Matthew Smith
Ralph Kirk
Robert Gibson
Shane McKenna
P2860
P304
P356
10.1002/CMDC.201300179
P577
2013-08-08T00:00:00Z